Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
of specific DNA repeats. We are seeking motivated candidate who has experience in the following aspects: Biology of C. elegans; cell culture particularly induced pluripotent stem cells and neurons; recombinant
-
experiments. Generation of lentiviral vector for in vivo or in vitro gene delivery; primary neuronal culture; human fibroblast and pluripotent stem cell culture. Compile and analyze data with appropriate
-
seek to understand the genetic and epigenetic basis of organ regeneration and tumorigenesis. We study the properties of stem/progenitor cells in diverse epithelial tissues (with a primary focus on lung
-
Our Plant Science research covers topics such as plant-environment interactions, cell signalling, cell and membrane biology, protein structure and function, gene regulation, synthetic biology
-
induced pluripotent stem cells (iPSCs); differentiation of pluripotent cells into neuronal lineages; genome engineering using CRISPR/Cas9; molecular biology and biochemistry laboratory techniques (e.g
-
hours as appropriate. Qualifications PhD in stem cell and regenerative biology or cell and molecular biology or a closely related field and/or an equivalent graduate degree plus at least five years of
-
also have conceptual, empirical, or ethical consequences. Given the ubiquitous role of lineages in biology (central to development, regeneration, stem cell biology, cancer biology, and more), a clearer
-
, research is vital to advance diagnosis, treatment and prevention. Our strength is in identifying and designing novel therapeutic strategies that will lead to clinical trials. PhD: 3-4 years full-time; 5
-
dynamic interactions with therapeutic immune cells. While expertise in in vitro immunotherapy modeling is highly desirable, candidates with the following experience will also be considered: stem cell
-
or induced pluripotent stem cells (iPSCs) derived from patient peripheral blood mononuclear cells. Validation will include stimulating or inhibiting target pathways using antagonists or agonists, or using gene